Literature DB >> 4146767

Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.

D T Mason, A N DeMaria, E A Amsterdam, R Zelis, R A Massumi.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4146767     DOI： 10.2165/00003495-197305040-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  62 in total

1.  SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT.

Authors:  H L CONN; R J LUCHI
Journal:  Am J Med       Date:  1964-11       Impact factor: 4.965

2.  The effect of the cardiac membrane potential on the rapid availability of the sodium-carrying system.

Authors:  S WEIDMANN
Journal:  J Physiol       Date:  1955-01-28       Impact factor: 5.182

3.  Single fiber recording of the effects of quinidine at atrial and pacemaker sites in the isolated right atrium of the rabbit.

Authors:  T C WEST; D W AMORY
Journal:  J Pharmacol Exp Ther       Date:  1960-10       Impact factor: 4.030

4.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

Review 5.  The use of beta-adrenergic receptor blocking drugs in dysrhythmias.

Authors:  D Gibson; E Sowton
Journal:  Prog Cardiovasc Dis       Date:  1969-07       Impact factor: 8.194

Review 6.  Pharmacology of cardiac arrhythmias.

Authors:  D H Singer; R E Ten Eick
Journal:  Prog Cardiovasc Dis       Date:  1969-05       Impact factor: 8.194

Review 7.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

8.  Propranolol and quinidine in the management of ventricular tachycardia.

Authors:  L S Dreifus; H F Lim; Y Watanabe; E McKnight; M N Frank
Journal:  JAMA       Date:  1968-05-20       Impact factor: 56.272

9.  Sotalol: a new, safe beta adrenergic receptor blocking agent.

Authors:  W S Frankl; L A Soloff
Journal:  Am J Cardiol       Date:  1968-08       Impact factor: 2.778

10.  Interactions of lanatoside C and potassium on atrioventricular conduction in rabbits.

Authors:  Y Watanabe; L S Dreifus
Journal:  Circ Res       Date:  1970-12       Impact factor: 17.367
View more
  7 in total

1.  Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

2.  Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.

Authors:  L Rydén; A Hjalmarson; H Wasir; L Werkö
Journal:  Br Heart J       Date:  1974-08

Review 3.  Clinical pharmacology and therapeutics use of digitalis glycosides.

Authors:  J E Doherty; J J Kane
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  Cardiac arrhythmias: theory and practice.

Authors:  J K Aronson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-16

5.  Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone.

Authors:  K Keller; G Meyer-Estorf; O A Beck; H Hochrein
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

Review 6.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

7.  The effects of disopyramide phosphate on early post-coronary artery ligation dysrhythmias and on epicardial ST-segment elevation in anaesthetized dogs.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1979-06       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.